Ever Evolving, Always Improving
MIGS has revolutionized glaucoma surgery, but there’s still room for improvement. Let’s talk XEN…
Daniel Lee | | Longer Read
The introduction of minimally invasive glaucoma surgery (MIGS) – the first generation iStent – back in 2008 signaled a big change in the way that we practiced glaucoma surgery and in the outcomes we were witnessing in patient safety and visual recovery. Since then, the MIGS philosophy has become pervasive; devices have been developed for every known target tissue in the aqueous fluid pathway and it feels like we hear about a novel device or new technique every year.
Figure 1. Ab externo implantation technique. (A)A traction suture is placed to aid in exposure. After the tip of the XEN45 stent is visualized, marked and retracted into the injector tip, (B) The injector enters the subconjunctival space and engages the sclera approximately 2 mm posterior to the limbus. (C) The XEN45 stent is deployed and visualized in the subconjunctival space. (D) A mirrored gonioscopic lens is used to confirm proper positioning of the stent.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine